Citeline, Trialtrove

2020 Clinical Trials Roundup: Disruptions to the Trial Landscape

25 Nov 2022

Our annual analysis dissects the data of all Phase I–III clinical trials that started in a year dominated by COVID-19.

Scrip

Pfizer Lays Out Multi-Phase COVID-19 Vaccine Commercial Strategy

By Jessica Merrill 14 Nov 2022

The pandemic phase will last through late 2021/early 2022, becoming a more seasonal opportunity for several years after, Pfizer management predicted during the company's second quarter call.

Biomedtracker, Datamonitor Healthcare

COVID-19 24 hour webinar recordings

31 Aug 2022

Catch up on any missed COVID-19 24 hour webinar sessions

Pharma Intelligence Apps

UK Adults Call on Pharma Companies to Keep Improving COVID-19 Treatments Without Sidelining Other Conditions

06 Jan 2022

London, 04.01.22 – Pharmaceutical companies must keep improving COVID-19 treatments in line with new variants without sidelining work in other areas of health, according to new data from YouGov and Informa Pharma Intelligence, the world’s leading intelligence provider for the biopharma industry.

Pharma Intelligence Apps

Americans Push for Rapid Pharma Innovation: Over a Quarter Believe a Better COVID-19 Vaccine Will Be Available in the Near Future

17 Dec 2021

New report from Informa Pharma Intelligence finds Americans are closely watching COVID-19 vaccine and treatment clinical trials as the U.S. continues to encounter new variants

Biomedtracker, Datamonitor Healthcare

2020 Deal-Making Roundup

21 Sep 2021

Against a backdrop of unprecedented disruption, the biopharma and medtech industries reached incredible heights for deal-making activity during 2020.

While Over Three-Quarters of Americans Are Willing to Take at Least One of the Authorized COVID-19 Vaccines, Nearly a Quarter Are Still Hesitant as the U.S. Changes Course on Mitigation Strategy

03 Jun 2021

New Informa Pharma Intelligence report shows that while vaccine hesitancy creates an uphill battle for herd immunity, virus manageability may be possible as the U.S. marches toward July 4 deadline of 70% of American adults partially vaccinated.  

Q2 2021 Clinical Trials and the COVID-19 Vaccine Pulse Report

By Karen Currie 03 Jun 2021

The goal of our second Clinical Trials & the COVID-19 Vaccine Pulse Report is to uncover who is still hesitant to take a vaccine, and what public health experts from pharma to the U.S. government can do to turn the tide.

Trialtrove

2020 Completed Trials A Bumpy Road for Industry Sponsored Clinical Studies

20 May 2021

Over the past five years, our analysis of completed trials consistently observed growth trends.